4.4 Article

First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents

期刊

ONCOLOGY
卷 94, 期 5, 页码 324-328

出版社

KARGER
DOI: 10.1159/000486680

关键词

Combinations in oncology; Dendrimers; Camptothecin; Cisplatin; Paclitaxel; Doxorubicin; MG132

类别

资金

  1. FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/QUI/UI0674/2013]
  2. ARDITI - Centro de Quimica da Madeira - CQM+ (Madeira 14-20) [M1420-01-0145-FEDER-000005]
  3. CNRS (France)

向作者/读者索取更多资源

The metallo-phosphorus dendrimer 1G3-Cu (generation 3 dendrimer bearing 48 conjugated copper(II) on its surface) has antiproliferative activity related to its capacity to activate Bax translocation. In the present study, we evaluate the activity of an association of 1G3-Cu with 5 cytotoxic agents used in chemotherapy having different modes of action. Data show no additive effect with camptothecin and cisplatin, additivity with paclitaxel and MG132, and synergy with doxorubicin. Results suggest that the multivalent Cu-conjugated dendrimer 1G3-Cu ( activator of Bax translocation) plays an important role in boosting the clinical impact of Bax accumulation stimulated by the proteasome inhibitor MG132, antimitotic taxanes, and the topo II inhibitor doxorubicin. (C) 2018 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据